Predicting Response to Radical Chemoradiotherapy with Circulating HPV DNA (cHPV-DNA) in Locally Advanced Uterine Cervix Cancer

SIMPLE SUMMARY: Cervix cancer is largely (95%) caused by human papilloma virus (HPV). Curative treatment for locally advanced cervical cancer (progressed beyond the cervix) is chemotherapy and radiotherapy (CRT), followed by internal radiation (brachytherapy). In approximately 30% of patients the ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalondrelle, Susan, Lee, Jen, Cutts, Rosalind J., Garcia Murillas, Isaac, Matthews, Nik, Turner, Nicholas, Harrington, Kevin, Vroobel, Katherine, Moretti, Emily, Bhide, Shreerang A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000151/
https://www.ncbi.nlm.nih.gov/pubmed/36900180
http://dx.doi.org/10.3390/cancers15051387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000151/
https://www.ncbi.nlm.nih.gov/pubmed/36900180
http://dx.doi.org/10.3390/cancers15051387

Ejemplares similares